Cited by 170Virus-based gene therapy researchHIV Research and TreatmentHIV/AIDS drug development and treatment

A Novel Co-Crystal Structure Affords the Design of Gain-of-Function Lentiviral Integrase Mutants in the Presence of Modified PSIP1/LEDGF/p75

Open access
Hare, Stephen, Shun, Ming-Chieh, Gupta, Saumya Shree, Valkov, Eugene, Engelman, Alan, Cherepanov, Peter·2009·PLoS Pathogens

Abstract

Lens epithelium derived growth factor (LEDGF), also known as PC4 and SFRS1 interacting protein 1 (PSIP1) and transcriptional co-activator p75, is the cellular binding partner of lentiviral integrase (IN) proteins. LEDGF accounts for the characteristic propensity of Lentivirus to integrate within active transcription units and is required for efficient viral replication. We now present a crystal structure containing the N-terminal and catalytic core domains (NTD and CCD) of HIV-2 IN in complex with the IN binding domain (IBD) of LEDGF. The structure extends the known IN-LEDGF interface, elucidating primarily charge-charge interactions between the NTD of IN and the IBD. A constellation of acidic residues on the NTD is characteristic of lentiviral INs, and mutations of the positively charged residues on the IBD severely affect interaction with all lentiviral INs tested. We show that the novel NTD-IBD contacts are critical for stimulation of concerted lentiviral DNA integration by LEDGF in vitro and for its function during the early steps of HIV-1 replication. Furthermore, the new structural details enabled us to engineer a mutant of HIV-1 IN that primarily functions only when presented with a complementary LEDGF mutant. These findings provide structural basis for the high affinity lentiviral IN-LEDGF interaction and pave the way for development of LEDGF-based targeting technologies for gene therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1000259

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • LEDGF/p75 residues Ile356 and Asp366 on the loop between alpha-helices 1 and 2 contact both integrase monomers of the CCD dimer, and electropositive residues on alpha-helix 4 contact electronegative residues of integrase NTD alpha-helix 1.

    “Residues Ile356 and Asp366 located on the loop between α-helices 1 and 2 mediate interactions with both IN monomers of the CCD dimer while electropositive residues on the outward face of α-helix 4 interface with electronegative residues of IN NTD α-helix 1 (REF.107,109).”

    From Structure and function of retroviral integrase (2022) · cites this paper as [107]

    The Introduction and Results section ‘The IN–LEDGF Interface and the Role of the IN NTD’ describe Asp-366 binding at the CCD interface and positively charged LEDGF α4 residues facing acidic residues on integrase NTD α1. They identify the pocket-binding residue as Ile-365, not Ile-356. The cited passages also do not establish that both named residues contact both CCD monomers. (LLM, conf=0.89)

    Experimental — accuracy not yet measured
  • The integrase CCD is the primary LEDGF/p75 binding determinant, with the NTD providing secondary contacts for full affinity.

    “The CCD is the main IN binding determinant, with the NTD contributing secondary interactions for full binding affinity106,107.”

    From Structure and function of retroviral integrase (2022) · cites this paper as [107]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 62 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. [55]Evans PR 1993 Data reduction. Proceedings of CCP4 Study Weekend, 1993, on Data Collection & Processing 114 122
  2. [61]McCoy AJ Grosse-Kunstleve RW Adams PD Winn MD Storoni LC 2007 Phaser crystallographic software. J Appl Cryst 40 658 674 19461840 PMC2483472

Cited by

Sorted by citations

Authors
Hare, S., Shun, M.-C., Gupta, S. S., Valkov, E., Engelman, A., & Cherepanov, P.
Affiliations
  • Imperial College London (GB)
  • Dana-Farber Cancer Institute (US)
Corresponding author
  • Engelman, Alan
  • Cherepanov, Peter
Venue
PLoS Pathogens
Published
2009-01-09
Volume
5
Issue
1
Pages
e1000259
ISSN
  • 1553-7366 (ISSN-L)
  • 1553-7374
OpenAlex
W2032297596
Cited by
166
References
62
Citations by year
2026: 3 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 6 · 2021: 6 · 2020: 6 · 2019: 4 · 2018: 6 · 2017: 6 · 2016: 7 · 2015: 15 · 2014: 26 · 2013: 11 · 2012: 13
FWCI
12.09
Type
journal article
Language
en
Open access
Locations
  • PLoS Pathogens (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Sussex Research Online (University of Sussex) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
  • University College London
  • European Synchrotron Radiation Facility (ID23‐1)
  • National Institutes of Health
  • Medical Research Council
  • National Institute of Allergy and Infectious Diseases (AI07245, AI70042, AI39394, R01AI039394, R01AI070042, R37AI039394, T32AI007245)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords
LEDGF, PSIP1, p75, HIV-1 integrase, crystal structure, gain-of-function mutants, charge-charge interactions, HIV-1 replication
MeSH terms
Humans, Mutation, Protein Binding, Transcription Factors, Virus Replication, HIV-2, Lentivirus, Crystallography, X-Ray, HIV Integrase, Adaptor Proteins, Signal Transducing, Human Immunodeficiency Virus Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review